81 results
S-3ASR
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading market for any … have authorized for use in connection with this offering. We and Jefferies take no responsibility for, and can provide no assurance
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting … sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii
424B5
xjdem58 9y
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
ekbdu6 0awgyw17vi4
4 Mar 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-1.1
pxyj54r 1v
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
424B5
t5nlho qljpu
17 May 23
Prospectus supplement for primary offering
4:45pm